Open-heart surgery increases cerebrospinal fluid levels of Alzheimer-associated amyloid β

Acta Anaesthesiologica Scandinavica

Volumn 57, Issue 1, 2013, Pages 82-88

  Reinsfelt, B ^a   Westerlind, A ^a   Blennow, K ^a   Zetterberg, H ^a,b   Ricksten, S E ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; INTERLEUKIN 6; INTERLEUKIN 8; PROTEIN PRECURSOR; TUMOR NECROSIS FACTOR ALPHA;

AGED; AORTA VALVE REPLACEMENT; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; OPEN HEART SURGERY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CYTOKINES; ENCEPHALITIS; FEMALE; HUMANS; MALE;

EID: 84870976744     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2012.02769.x     Document Type: Article

References (35)

1. Bucerius J, Gummert JF, Borger MA, Walther T, Doll N, Onnasch JF, Metz S, Falk V, Mohr FW. Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients. Ann Thorac Surg 2003; 75: 472-8.
2. Selim M. Perioperative stroke. N Engl J Med 2007; 356: 706-13.
3. Newman MF, Mathew JP, Grocott HP, Mackensen GB, Monk T, Welsh-Bohmer KA, Blumenthal JA, Laskowitz DT, Mark DB. Central nervous system injury associated with cardiac surgery. Lancet 2006; 368: 694-703.
4. Lombard FW, Mathew JP. Neurocognitive dysfunction following cardiac surgery. Semin Cardiothorac Vasc Anesth 2010; 14: 102-10.
5. Grocott HP, Homi HM, Puskas F. Cognitive dysfunction after cardiac surgery: revisiting etiology. Semin Cardiothorac Vascular Anesth 2005; 9: 123-29.
6. Gao L, Taha R, Gauvin D, Othmen LB, Wang Y, Blaise G. Postoperative cognitive dysfunction after cardiac surgery. Chest 2005; 128: 3664-70.
7. Hall RI, Smith MS, Rocker G. The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg 1997; 85: 766-82.
8. Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 1997; 112: 676-92.
9. Brown WR, Moody DM, Tytell M, Ghazi-Birry HS, Challa VR. Microembolic brain injuries from cardiac surgery: are they seeds of future Alzheimers disease? Ann N Y Acad Sci 1997; 826: 386-9.
10. Emmrich P, Hahn J, Ogunlade V, Geiger K, Schober R, Mohr FW. [Neuropathological findings after cardiac surgeryretrospective study over 6 years]. Z Kardiol 2003; 92: 925-37.
11. Sparks DL, Martin TA, Gross DR, Hunsaker JC, 3rd. Link between heart disease, cholesterol, and Alzheimers disease: a review. Microsc Res Tech 2000; 50: 287-90.
12. Tardiff BE, Newman MF, Saunders AM, Strittmatter WJ, Blumenthal JA, White WD, Croughwell ND, Davis RD, Jr, Roses AD, Reves JG. Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center. Ann Thorac Surg 1997; 64: 715-20.
13. Lee TA, Wolozin B, Weiss KB, Bednar MM. Assessment of the emergence of Alzheimers disease following coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty. J Alzheimers Dis 2005; 7: 319-24.
14. Cacquevel M, Lebeurrier N, Cheenne S, Vivien D. Cytokines in neuroinflammation and Alzheimers disease. Curr Drug Targets 2004; 5: 529-34.
15. McGeer EG, McGeer PL. Brain inflammation in Alzheimer disease and the therapeutic implications. Curr Pharm Des 1999; 5: 821-36.
16. Mrak RE, Sheng JG, Griffin WS. Glial cytokines in Alzheimers disease: review and pathogenic implications. Hum Pathol 1995; 26: 816-23.
17. Tuppo EE, Arias HR. The role of inflammation in Alzheimers disease. Int J Biochem Cell Biol 2005; 37: 289-305.
18. Hoozemans JJ, Rozemuller AJ, Veerhuis R, Eikelenboom P. Immunological aspects of Alzheimers disease: therapeutic implications. BioDrugs 2001; 15: 325-37.
19. Zetterberg H, Hietala MA, Jonsson M, Andreasen N, Styrud E, Karlsson I, Edman A, Popa C, Rasulzada A,Wahlund LO, Mehta PD, Rosengren L, Blennow K,Wallin A. Neurochemical aftermath of amateur boxing. Arch Neurol 2006; 63: 1277-80.
20. Burkhart C, Siegemund M, Steiner L. Cerebral perfusion in sepsis. Crit Care 2010; 14: 215.
21. Ebersoldt M, Sharshar T, Annane D. Sepsis-associated delirium. Intensive Care Med 2007; 33: 941-50.
22. Rogers J, Lue LF. Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimers disease. Neurochem Int 2001; 39: 333-40.
23. Flierl MA, Stahel PF, Touban BM, Beauchamp KM, Morgan SJ, Smith WR, Ipaktchi KR. Bench-to-bedside review: burninduced cerebral inflammation - a neglected entity? Crit Care (London, England) 2009; 13: 215.
24. Blennow K, Hampel H, Weiner M, Zetterberg H. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 2010; 6: 131-44.
25. Portelius E, Brinkmalm G, Tran A, Andreasson U, Zetterberg H, Westman-Brinkmalm A, Blennow K, Ohrfelt A. Identification of novel N-terminal fragments of amyloid precursor protein in cerebrospinal fluid. Exp Neurol 2010; 223: 351-8.
26. Bitting L, Naidu A, Cordell B, Murphy GM, Jr. Beta-amyloid peptide secretion by a microglial cell line is induced by beta-amyloid-(25-35) and lipopolysaccharide. J Biol Chem 1996; 271: 16084-9.
27. Koike MA, Green KN, Blurton-Jones M, Laferla FM. Oligemic hypoperfusion differentially affects tau and amyloid-{beta}. Am J Pathol 2010; 177: 300-10.
28. Wang X, Xing A, Xu C, Cai Q, Liu H, Li L. Cerebrovascular hypoperfusion induces spatial memory impairment, synaptic changes, and amyloid-beta oligomerization in rats. J Alzheimers Dis 2010; 21: 813-22.
29. Zetterberg H, Mortberg E, Song L, Chang L, Provuncher GK, Patel PP, Ferrell E, Fournier DR, Kan CW, Campbell TG, Meyer R, Rivnak AJ, Pink BA, Minnehan KA, Piech T, Rissin DM, Duffy DC, Rubertsson S, Wilson DH, Blennow K. Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid beta levels in humans. PLoS ONE 2011; 6: e28263.
30. Palotas A, Reis HJ, Bogats G, Babik B, Racsmany M, Engvau L, Kecskemeti E, Juhasz A, Vieira LB, Teixeira AL, Mukhamedyarovi MA, Rizvanov AA, Yalvac ME, Guimaraes MM, Ferreira CN, Zefirov AL, Kiyasov AP, Wang L, Janka Z, Kalman J. Coronary artery bypass surgery provokes Alzheimers disease-like changes in the cerebrospinal fluid. J Alzheimers Dis 2010; 21: 1153-64.
31. Raja SG, Berg GA. Impact of off-pump coronary artery bypass surgery on systemic inflammation: current best available evidence. J Card Surg 2007; 22: 445-55.
32. Fodale V, Santamaria LB, Schifilliti D, Mandal PK. Anaesthetics and postoperative cognitive dysfunction: a pathological mechanism mimicking Alzheimers disease. Anaesthesia 2010; 65: 388-95.
33. Xie Z, Dong Y, Maeda U, Alfille P, Culley DJ, Crosby G, Tanzi RE. The common inhalation anesthetic isoflurane induces apoptosis and increases amyloid beta protein levels. Anesthesiology 2006; 104: 988-94.
34. Xie Z, Culley DJ, Dong Y, Zhang G, Zhang B, Moir RD, Frosch MP, Crosby G, Tanzi RE. The common inhalation anesthetic isoflurane induces caspase activation and increases amyloid beta-protein level in vivo. Ann Neurol 2008; 64: 618-27.
35. Tang JX, Baranov D, Hammond M, Shaw LM, Eckenhoff MF, Eckenhoff RG. Human Alzheimer and inflammation biomarkers after anesthesia and surgery. Anesthesiology 2011; 115: 727-32.